| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disorders of Sex Development | 7 | 2020 | 78 | 1.590 |
Why?
|
| Androgen-Insensitivity Syndrome | 3 | 2015 | 27 | 0.840 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 2 | 2020 | 9 | 0.780 |
Why?
|
| Adrenal Hyperplasia, Congenital | 3 | 2018 | 34 | 0.720 |
Why?
|
| Sex Reassignment Procedures | 3 | 2017 | 18 | 0.690 |
Why?
|
| Pigmentation Disorders | 1 | 2020 | 23 | 0.680 |
Why?
|
| Hypoadrenocorticism, Familial | 1 | 2019 | 2 | 0.670 |
Why?
|
| Genital Diseases, Male | 1 | 2018 | 12 | 0.620 |
Why?
|
| Vomiting | 1 | 2019 | 115 | 0.620 |
Why?
|
| Kallmann Syndrome | 1 | 2018 | 15 | 0.620 |
Why?
|
| Accidental Falls | 1 | 2020 | 106 | 0.610 |
Why?
|
| Penis | 1 | 2018 | 97 | 0.580 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 17 | 0.530 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2023 | 795 | 0.520 |
Why?
|
| Puberty, Precocious | 3 | 2019 | 27 | 0.520 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 110 | 0.480 |
Why?
|
| Gender Identity | 4 | 2017 | 70 | 0.470 |
Why?
|
| Testis | 3 | 2020 | 405 | 0.440 |
Why?
|
| Phenotype | 9 | 2023 | 4223 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 1255 | 0.400 |
Why?
|
| Endocrinology | 1 | 2014 | 139 | 0.390 |
Why?
|
| Hypothyroidism | 2 | 2007 | 89 | 0.380 |
Why?
|
| Terminology as Topic | 3 | 2020 | 229 | 0.350 |
Why?
|
| Thyroid Gland | 3 | 2021 | 112 | 0.350 |
Why?
|
| Child, Preschool | 17 | 2023 | 13882 | 0.340 |
Why?
|
| Brain | 3 | 2019 | 2964 | 0.310 |
Why?
|
| Testosterone | 2 | 2018 | 462 | 0.300 |
Why?
|
| Familial Hypophosphatemic Rickets | 1 | 2007 | 8 | 0.300 |
Why?
|
| Patient Care Team | 3 | 2021 | 548 | 0.290 |
Why?
|
| Point Mutation | 2 | 2006 | 348 | 0.290 |
Why?
|
| Humans | 49 | 2023 | 123032 | 0.290 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 65 | 0.290 |
Why?
|
| Hemangioendothelioma | 1 | 2007 | 25 | 0.270 |
Why?
|
| Receptors, LHRH | 1 | 2006 | 14 | 0.270 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 50 | 0.270 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 51 | 0.270 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 54 | 0.260 |
Why?
|
| Chorionic Gonadotropin | 1 | 2006 | 83 | 0.260 |
Why?
|
| Male | 27 | 2020 | 60065 | 0.260 |
Why?
|
| Child | 20 | 2023 | 24222 | 0.260 |
Why?
|
| Puberty | 2 | 2016 | 94 | 0.250 |
Why?
|
| Hypospadias | 2 | 2018 | 81 | 0.250 |
Why?
|
| Pediatrics | 1 | 2014 | 1141 | 0.250 |
Why?
|
| Sexual Development | 2 | 2019 | 23 | 0.250 |
Why?
|
| Respiratory Insufficiency | 1 | 2007 | 231 | 0.240 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 408 | 0.240 |
Why?
|
| Dexamethasone | 2 | 2018 | 271 | 0.230 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2023 | 8 | 0.220 |
Why?
|
| Decision Making | 1 | 2009 | 653 | 0.220 |
Why?
|
| Infant, Newborn | 10 | 2020 | 8105 | 0.220 |
Why?
|
| Female | 30 | 2021 | 65496 | 0.210 |
Why?
|
| Androgens | 2 | 2015 | 256 | 0.210 |
Why?
|
| Diagnosis, Differential | 6 | 2019 | 1877 | 0.210 |
Why?
|
| Adolescent | 15 | 2021 | 19102 | 0.200 |
Why?
|
| Pituitary Neoplasms | 2 | 2009 | 83 | 0.200 |
Why?
|
| Prenatal Diagnosis | 3 | 2018 | 588 | 0.200 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 1309 | 0.190 |
Why?
|
| Obesity, Morbid | 1 | 2023 | 184 | 0.190 |
Why?
|
| Thyroid Neoplasms | 2 | 2021 | 197 | 0.190 |
Why?
|
| Infant | 9 | 2022 | 12346 | 0.190 |
Why?
|
| Disclosure | 2 | 2015 | 154 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2007 | 995 | 0.180 |
Why?
|
| Sudden Infant Death | 1 | 2020 | 33 | 0.180 |
Why?
|
| Encephalocele | 2 | 2015 | 51 | 0.170 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 26 | 0.170 |
Why?
|
| Femoral Fractures | 1 | 2020 | 33 | 0.170 |
Why?
|
| Leydig Cell Tumor | 1 | 2019 | 7 | 0.160 |
Why?
|
| Tibial Fractures | 1 | 2020 | 59 | 0.160 |
Why?
|
| Patients | 1 | 2020 | 121 | 0.160 |
Why?
|
| Codon, Nonsense | 2 | 2012 | 131 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2020 | 91 | 0.160 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 134 | 0.160 |
Why?
|
| Orchiectomy | 1 | 2019 | 44 | 0.160 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.160 |
Why?
|
| Leg | 1 | 2020 | 155 | 0.160 |
Why?
|
| Cyclic AMP | 2 | 2012 | 247 | 0.160 |
Why?
|
| Informed Consent | 2 | 2015 | 341 | 0.160 |
Why?
|
| Thrombocytopenia | 2 | 2015 | 228 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 2 | 2023 | 19 | 0.160 |
Why?
|
| Pediatric Obesity | 1 | 2023 | 379 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
| Hormones | 1 | 2019 | 191 | 0.150 |
Why?
|
| Sexual Maturation | 1 | 2018 | 48 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2020 | 259 | 0.150 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1014 | 0.150 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 73 | 0.150 |
Why?
|
| Pedigree | 3 | 2007 | 1581 | 0.150 |
Why?
|
| Sex Determination Processes | 1 | 2017 | 12 | 0.150 |
Why?
|
| Risperidone | 1 | 2018 | 60 | 0.150 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 247 | 0.150 |
Why?
|
| Testicular Neoplasms | 1 | 2019 | 132 | 0.150 |
Why?
|
| Sex Counseling | 1 | 2017 | 7 | 0.140 |
Why?
|
| Mythology | 1 | 2017 | 9 | 0.140 |
Why?
|
| Recurrence | 2 | 2019 | 1419 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2019 | 456 | 0.130 |
Why?
|
| Turner Syndrome | 1 | 2016 | 47 | 0.130 |
Why?
|
| Insulin | 3 | 2005 | 1200 | 0.130 |
Why?
|
| Erucic Acids | 1 | 1995 | 2 | 0.130 |
Why?
|
| Triolein | 1 | 1995 | 3 | 0.130 |
Why?
|
| Blood Glucose | 3 | 2022 | 1119 | 0.130 |
Why?
|
| Adrenoleukodystrophy | 1 | 1995 | 9 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 505 | 0.130 |
Why?
|
| Ectromelia | 1 | 2015 | 5 | 0.120 |
Why?
|
| Gonads | 1 | 2015 | 36 | 0.120 |
Why?
|
| Genitalia | 1 | 2015 | 36 | 0.120 |
Why?
|
| ACTH Syndrome, Ectopic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Adenoma | 1 | 1996 | 133 | 0.120 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2015 | 8 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2015 | 17 | 0.120 |
Why?
|
| Parents | 4 | 2023 | 1031 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 3546 | 0.120 |
Why?
|
| Adult | 9 | 2023 | 29012 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 2015 | 29 | 0.120 |
Why?
|
| Caregivers | 1 | 2020 | 572 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 67 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2015 | 964 | 0.120 |
Why?
|
| Siblings | 2 | 2023 | 196 | 0.120 |
Why?
|
| Pregnancy | 5 | 2018 | 7161 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 263 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 426 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 1265 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 398 | 0.110 |
Why?
|
| DNA Mutational Analysis | 2 | 2006 | 793 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 1995 | 577 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2015 | 168 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 622 | 0.100 |
Why?
|
| Estrogens | 1 | 2015 | 508 | 0.100 |
Why?
|
| Thyroxine | 2 | 2007 | 65 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2019 | 1477 | 0.100 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2012 | 5 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 2012 | 12 | 0.100 |
Why?
|
| Time Factors | 3 | 2018 | 6217 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1528 | 0.090 |
Why?
|
| Aromatase Inhibitors | 1 | 2011 | 75 | 0.090 |
Why?
|
| Nitriles | 1 | 2011 | 145 | 0.090 |
Why?
|
| Triazoles | 1 | 2011 | 138 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 313 | 0.080 |
Why?
|
| Heterozygote | 3 | 2007 | 672 | 0.080 |
Why?
|
| Pituitary Diseases | 1 | 2009 | 10 | 0.080 |
Why?
|
| Risk Factors | 5 | 2018 | 10006 | 0.080 |
Why?
|
| Germinoma | 1 | 2009 | 31 | 0.080 |
Why?
|
| Chromogranins | 2 | 2023 | 27 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 188 | 0.080 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2009 | 31 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2019 | 2585 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 673 | 0.080 |
Why?
|
| Consensus | 1 | 2012 | 605 | 0.080 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2007 | 6 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2009 | 327 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 371 | 0.070 |
Why?
|
| Phosphates | 1 | 2007 | 111 | 0.070 |
Why?
|
| Sex | 1 | 2007 | 8 | 0.070 |
Why?
|
| Thyrotropin | 1 | 2007 | 58 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 41 | 0.070 |
Why?
|
| Triiodothyronine | 1 | 2007 | 63 | 0.070 |
Why?
|
| Mutation | 1 | 2020 | 5771 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 614 | 0.070 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2006 | 1 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 96 | 0.070 |
Why?
|
| Calcitriol | 1 | 2006 | 80 | 0.070 |
Why?
|
| Magnesium | 1 | 2006 | 121 | 0.070 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2006 | 15 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 52 | 0.070 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 112 | 0.060 |
Why?
|
| Insulin Infusion Systems | 1 | 2005 | 61 | 0.060 |
Why?
|
| Body Height | 1 | 2006 | 210 | 0.060 |
Why?
|
| Gene Expression | 2 | 2006 | 1566 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2006 | 262 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 822 | 0.060 |
Why?
|
| Syntaxin 16 | 1 | 2023 | 5 | 0.060 |
Why?
|
| Germany | 1 | 2004 | 66 | 0.060 |
Why?
|
| Brazil | 1 | 2004 | 120 | 0.060 |
Why?
|
| Hyperphagia | 1 | 2023 | 46 | 0.060 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2005 | 171 | 0.050 |
Why?
|
| Thyroidectomy | 2 | 2021 | 102 | 0.050 |
Why?
|
| Family Health | 1 | 2004 | 259 | 0.050 |
Why?
|
| Genome, Human | 1 | 2009 | 1264 | 0.050 |
Why?
|
| United States | 3 | 2018 | 10639 | 0.050 |
Why?
|
| Hypoaldosteronism | 1 | 2001 | 1 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 191 | 0.050 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renin | 1 | 2001 | 89 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 924 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 1096 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 221 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2006 | 799 | 0.050 |
Why?
|
| Students | 1 | 2023 | 251 | 0.050 |
Why?
|
| Amish | 1 | 2020 | 9 | 0.050 |
Why?
|
| Neoplasms | 1 | 2015 | 2758 | 0.040 |
Why?
|
| Genotype | 1 | 2006 | 2535 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2022 | 256 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2014 | 12118 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5045 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 345 | 0.040 |
Why?
|
| Virilism | 1 | 2018 | 14 | 0.040 |
Why?
|
| Parenting | 1 | 2022 | 328 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 2838 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 657 | 0.040 |
Why?
|
| Sex Preselection | 1 | 2017 | 7 | 0.040 |
Why?
|
| Gender Dysphoria | 1 | 2017 | 7 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2017 | 14 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 21 | 0.040 |
Why?
|
| Greece, Ancient | 1 | 2017 | 10 | 0.040 |
Why?
|
| Sex Reassignment Surgery | 1 | 2017 | 10 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 849 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 753 | 0.040 |
Why?
|
| History, Ancient | 1 | 2017 | 54 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2023 | 987 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 1996 | 20 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2006 | 3315 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 779 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 386 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2016 | 60 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 269 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 77 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1389 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1995 | 34 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 761 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2015 | 76 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1995 | 269 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2696 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 375 | 0.030 |
Why?
|
| Physical Examination | 1 | 1995 | 165 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 880 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 125 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2015 | 215 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Hypoglycemia | 2 | 2005 | 191 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 3042 | 0.030 |
Why?
|
| Adrenal Cortex | 1 | 2012 | 10 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2012 | 23 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2018 | 1541 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 16028 | 0.020 |
Why?
|
| Learning | 1 | 1995 | 362 | 0.020 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2012 | 17 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2401 | 0.020 |
Why?
|
| Amniocentesis | 1 | 1992 | 78 | 0.020 |
Why?
|
| Adrenal Insufficiency | 1 | 2012 | 29 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3367 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2011 | 88 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 160 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 712 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 8849 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3718 | 0.020 |
Why?
|
| HLA Antigens | 1 | 1992 | 243 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 195 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 315 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 30 | 0.020 |
Why?
|
| Sella Turcica | 1 | 2009 | 5 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 468 | 0.020 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2009 | 5 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3015 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 614 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2009 | 84 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1012 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2009 | 172 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 109 | 0.020 |
Why?
|
| Incidence | 2 | 2006 | 3042 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 358 | 0.020 |
Why?
|
| Gestational Age | 1 | 1992 | 1138 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 574 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6026 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2054 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 638 | 0.020 |
Why?
|
| Spain | 1 | 2006 | 53 | 0.020 |
Why?
|
| Insulin, Long-Acting | 1 | 2005 | 5 | 0.020 |
Why?
|
| Insulin Glargine | 1 | 2005 | 8 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2809 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2006 | 175 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1680 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 54 | 0.010 |
Why?
|
| Extremities | 1 | 2004 | 83 | 0.010 |
Why?
|
| Texas | 1 | 2012 | 3560 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 724 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 269 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 360 | 0.010 |
Why?
|
| Fludrocortisone | 1 | 2001 | 2 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 17512 | 0.010 |
Why?
|
| Aldosterone | 1 | 2001 | 59 | 0.010 |
Why?
|
| Child Development | 1 | 2004 | 261 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 74 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 1115 | 0.010 |
Why?
|
| Introns | 1 | 2001 | 302 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 4702 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 279 | 0.010 |
Why?
|
| Exons | 1 | 2001 | 794 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 1292 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2826 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 33767 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 151 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1996 | 229 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 3077 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 1237 | 0.010 |
Why?
|